[{"address1": "2200 Bridge Pkwy", "address2": "Suite 102", "city": "Redwood City", "state": "CA", "zip": "94065", "country": "United States", "phone": "650 549 1400", "website": "https://jaspertx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ronald A. Martell", "age": 62, "title": "President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1036363, "exercisedValue": 0, "unexercisedValue": 238085}, {"maxAge": 1, "name": "Dr. Judith Anne Shizuru M.D., Ph.D.", "age": 68, "title": "Co-Founder, Member of Scientific Advisory Board & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 296300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Herbert C. Cross CPA", "age": 52, "title": "CFO & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 658208, "exercisedValue": 0, "unexercisedValue": 233413}, {"maxAge": 1, "name": "Mr. Jeetinder Singh Mahal M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 665399, "exercisedValue": 0, "unexercisedValue": 237695}, {"maxAge": 1, "name": "Mr. Matthew  Ford", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wendy  Pang M.D., Ph.D.", "title": "Senior Vice President of Research & Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel C. Adelman M.D.", "age": 67, "title": "Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Luca  Di Noto Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia  Carlos", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly  Baxter", "title": "VP & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.86, "open": 1.84, "dayLow": 1.805, "dayHigh": 1.96, "regularMarketPreviousClose": 1.86, "regularMarketOpen": 1.84, "regularMarketDayLow": 1.805, "regularMarketDayHigh": 1.96, "payoutRatio": 0.0, "beta": 3.064, "forwardPE": -0.56452763, "volume": 1393858, "regularMarketVolume": 1393858, "averageVolume": 1524257, "averageVolume10days": 772560, "averageDailyVolume10Day": 772560, "bid": 1.26, "ask": 1.91, "bidSize": 2, "askSize": 2, "marketCap": 52050316, "fiftyTwoWeekLow": 1.39, "fiftyTwoWeekHigh": 22.985, "allTimeHigh": 188.8, "allTimeLow": 1.39, "fiftyDayAverage": 1.9877, "twoHundredDayAverage": 3.53025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2854312, "profitMargins": 0.0, "floatShares": 21701342, "sharesOutstanding": 27984039, "sharesShort": 1831825, "sharesShortPriorMonth": 1525711, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0655, "heldPercentInsiders": 0.01045, "heldPercentInstitutions": 0.74064004, "shortRatio": 4.45, "shortPercentOfFloat": 0.0659, "impliedSharesOutstanding": 27984039, "bookValue": 0.413, "priceToBook": 4.503632, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -91021000, "trailingEps": -5.82, "forwardEps": -3.29479, "lastSplitFactor": "1:10", "lastSplitDate": 1704326400, "enterpriseToEbitda": -0.032, "52WeekChange": -0.9159132, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 1.86, "targetHighPrice": 51.0, "targetLowPrice": 4.0, "targetMeanPrice": 17.85714, "targetMedianPrice": 12.0, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 50899000, "totalCashPerShare": 1.819, "ebitda": -90511000, "totalDebt": 1703000, "quickRatio": 2.419, "currentRatio": 2.593, "debtToEquity": 14.718, "returnOnAssets": -0.72923, "returnOnEquity": -1.91118, "freeCashflow": -42694248, "operatingCashflow": -76428000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "JSPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Jasper Therapeutics, Inc.", "longName": "Jasper Therapeutics, Inc.", "averageDailyVolume3Month": 1524257, "fiftyTwoWeekLowChange": 0.47000003, "fiftyTwoWeekLowChangePercent": 0.33812952, "fiftyTwoWeekRange": "1.39 - 22.985", "fiftyTwoWeekHighChange": -21.125, "fiftyTwoWeekHighChangePercent": -0.91907763, "fiftyTwoWeekChangePercent": -91.591324, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.82, "epsForward": -3.29479, "epsCurrentYear": -4.80269, "priceEpsCurrentYear": -0.38728297, "fiftyDayAverageChange": -0.12769997, "fiftyDayAverageChangePercent": -0.06424509, "twoHundredDayAverageChange": -1.67025, "twoHundredDayAverageChangePercent": -0.47312513, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Amplitude Healthcare Acquisition Corporation", "nameChangeDate": "2025-12-14", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1578666600000, "marketState": "CLOSED", "regularMarketPrice": 1.86, "corporateActions": [], "postMarketTime": 1766188295, "regularMarketTime": 1766178003, "exchange": "NCM", "messageBoardId": "finmb_647336542", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "postMarketChangePercent": 1.6129017, "postMarketPrice": 1.89, "postMarketChange": 0.029999971, "regularMarketChange": 0.0, "regularMarketDayRange": "1.805 - 1.96", "fullExchangeName": "NasdaqCM", "displayName": "Jasper Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]